In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

This week's exercise is a perfect addition for someone on a GLP-1 prescription, because it addresses another element of ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

More than 38 million people in the U.S. are living with diabetes.

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

The decline of real-life slimming clubs is down to a variety of factors, says Kate. ‘Diets come in fads — at the moment, ...